MarketBeat on MSN7h
What Does the Future Hold for Eli Lilly?GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback